{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:03:53Z","timestamp":1761102233859},"reference-count":17,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2017,1,2]]},"DOI":"10.1080\/03007995.2016.1232704","type":"journal-article","created":{"date-parts":[[2016,9,3]],"date-time":"2016-09-03T00:43:01Z","timestamp":1472863381000},"page":"23-29","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Social preference weights for treatments in Fabry disease in the UK: a discrete choice experiment"],"prefix":"10.1080","volume":"33","author":[{"given":"Andrew J.","family":"Lloyd","sequence":"first","affiliation":[{"name":"Bladon Associates Ltd., Oxford, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katy","family":"Gallop","sequence":"additional","affiliation":[{"name":"Bladon Associates Ltd., Bristol, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shehzad","family":"Ali","sequence":"additional","affiliation":[{"name":"University of York, York, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derralynn","family":"Hughes","sequence":"additional","affiliation":[{"name":"Royal Free Hospital, London, UK;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alasdair","family":"MacCulloch","sequence":"additional","affiliation":[{"name":"Amicus Therapeutics Ltd., London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,9,16]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-30"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.06.029"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.3.249"},{"key":"CIT0004","volume-title":"The Metabolic & Molecular Bases of Inherited Disease","volume":"4","author":"Scriver CR","year":"2001"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2010.11.013"},{"key":"CIT0006","volume-title":"Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England","author":"Devlin N","year":"2016"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2011.11.004"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"CIT0009","unstructured":"Summary of Product Characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000370\/WC500020547.pdf. Accessed in January 2016"},{"key":"CIT0010","unstructured":"Summary of Product Characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/000369\/WC500053612.pdf. Accessed in January 2016"},{"key":"CIT0011","doi-asserted-by":"crossref","unstructured":"Beck M, Hughes D, Kampmann C, et\u00a0al. Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: a Fabry Outcome Survey analysis. Molecular Genetics and Metabolism Reports 2015;3:21-7","DOI":"10.1016\/j.ymgmr.2015.02.002"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2014.01.014"},{"key":"CIT0013","unstructured":"Summary of Product Characteristics. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/004059\/WC500208434.pdf. Accessed in January 2016"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014121226"},{"key":"CIT0015","unstructured":"World Bank. Available at: http:\/\/data.worldbank.org\/indicator\/SP.DYN.LE00.IN [Last accessed 25 February 2016]"},{"key":"CIT0016","unstructured":"Office for National Statistics. Available at: https:\/\/www.ons.gov.uk [Last accessed 16 Feburary 2016]"},{"key":"CIT0017","volume-title":"Guide to the Methods of Technology Appraisal","author":"National Institute for Health and Clinical Excellence (NICE).","year":"2013"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2016.1232704","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T23:36:46Z","timestamp":1599349006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2016.1232704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,16]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1,2]]}},"alternative-id":["10.1080\/03007995.2016.1232704"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2016.1232704","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-08-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-09-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}